BIODESIX, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
BIODESIX, INC. (BDSX) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $95.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-26
- BIODESIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $95.00K, a 97.92% increase from fiscal 2024.
- BIODESIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $48.00K, a 15.79% decline from fiscal 2023.
- BIODESIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $57.00K, a 47.71% decline from fiscal 2022.
- BIODESIX, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $109.00K, a 14.84% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $95.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $48.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $57.00K 10-K · filed 2025-03-03 |
| 2022-12-31 | $109.00K 10-K · filed 2024-03-01 |
| 2021-12-31 | $128.00K 10-K · filed 2023-03-06 |
| 2020-12-31 | $106.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |